3.30–4.30pm 28 July 2017
Ben Hayes, The University of Queensland, QLD
12–1pm 28 July 2017
Professor Glenda Halliday, Professor of Neuroscience, NHMRC Senior Principal Research Fellow, University of Sydney, Sydney, NSW
Many believe that the assessment of post-mortem brain tissue from people with...
2.30–3.30pm 26 July 2017
Investigating the immune context of human cancer
Associate Professor Paul Neeson, Human Immunology Translational Research Laboratory, Peter MacCallum Cancer Centre
Tools for Quantitative Pathology
12–1pm 26 July 2017
Dr Melisa Gorosito Serran, The Vinuesa Group, JCSMR
26 July 2017
This week, JCSMR will host the ACT Finals of the Australian Brain Bee Challenge -
The Australian Brain Bee Challenge (ABBC) is a competition for high school students in year 10 to learn about the brain and its functions, learn...
12–1pm 21 July 2017
Dr Kaylene Young, Menzies Institute for Medical Research, TAS
Oligodendrocyte progenitor cells (OPCs) remain as immature cells in the mature brain, where they continue to divide and generate new oligodendrocytes throughout...
12–1pm 19 July 2017
Dr SImon Jiang, The Vinuesa Group, JCSMR
3.30–4.30pm 7 July 2017
Dr Amee George, Manager, Target and Drug Discovery Platform, JCSMR
Dr George obtained her PhD in 2007 from the Department of Pathology at the University of Melbourne. With an interest in functional genomics, in 2008, she...
3.30–4.40pm 6 July 2017
Dr Hardip Patel, The Easteal Group, Genome Diversity and Health, JCSMR
12–1pm 30 June 2017
Professor Ricky Johnstone received his PhD from the University of Melbourne in 1993 and after a postdoc at Harvard Medical School returned to Melbourne to establish the Gene Regulation Laboratory at the Peter MacCallum Cancer...
2.10pm 26 June 2017
PLEASE NOTE: THERE IS NO JCSMR PUBLIC LECTURE TONIGHT, MONDAY 26 JUNE.
THE EVENT HAS BEEN UNFORTUNATELY CANCELLED.
3.30–4.30pm 23 June 2017
Mr Yadollah Ranjbar Slamloo, The Arabzadeh Group, JCSMR, ANU
12–1pm 23 June 2017
Dr Amee George, Manager, ACRF Target and Drug Discovery Platform, JCSMR
High throughput screening (HTS) is a way of rapidly assessing a large number of candidate compounds or genetic modulators to identify those which can...
12–1pm 16 June 2017
Dr Minni Änkö, Head - RNA Processing in Health and Disease Laboratory, Biomedicine Discovery Institute/Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC
The life and function of RNA is...
12–1pm 14 June 2017
Extracellular matrix in beta cell health and diseases
Associate Professor Charmaine Simeonovic, The Simeonovic Group - Diabetes/Transplantation Immunology, JCSMR
Untangling the B cell response to Malaria...
3.30–4.30pm 9 June 2017
Angel Lu, Provis/Valter Group, The Eccles Institute of Neuroscience, JCSMR, ANU
12–1pm 9 June 2017
Associate Professor Ross Laybutt, Garvan Institute of Medical Research, Sydney, NSW
Type 2 diabetes arises in subjects with islet beta cells that are susceptible to dysfunction and death under conditions of high insulin demand...
3.30–4.30pm 8 June 2017
Dr Alexandra Hackmann, The Fischer Group - Epigenetics and Genome Stability, JCSMR
Seminar will be followed by drinks in The Staff Tearoom.
12–1pm 5 June 2017
Genotype/Phenotype Relations of Nfkb2 in the Immune System
Ainsley Davies, The Cook Group, Department of Immunology and Infectious Disease, JCSMR, ANU, and The Canberra Hospital
Using Noscapine Derivatives to...
12–1pm 2 June 2017
Professor Paul A Gleeson, Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, VIC
The Golgi apparatus is a highly dynamic organelle at...